[CRISPR/Cas9 SAM (synergic activation mediator): a new strategy to screen for genome-encoded antiviral restriction factors]

Med Sci (Paris). 2018 May;34(5):401-403. doi: 10.1051/medsci/20183405010. Epub 2018 Jun 13.
[Article in French]
No abstract available

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • CRISPR-Cas Systems / genetics*
  • Genetic Testing / methods*
  • Humans
  • Virus Diseases / immunology*

Substances

  • Antiviral Agents